Novo Nordisk Alzheimer's Drug Trials Fail
Danish pharmaceutical giant Novo Nordisk faces major setback as Alzheimer's drug trials fail. Learn how this impacts the weight-loss leader's expansion plans.
Category : Search result: pharmaceutical stocks
Video Game Stocks Boom: ETF Beats S&P 500
The Roundhill Video Games ETF has surged, outperforming the S&P 500. Discover the drivers behind the boom, from the Nintendo Switch 2 to the EA buyout, and what it means for investors.
AI Bubble Bust Could Trigger 30% Market Crash
Capital Economics warns an AI bubble burst could cause S&P 500 to drop 30% and tech sectors 60%, though not immediately. Learn what's different from dot-com crash.
Buffett Buys Alphabet, Stock Gains 9% in Turbulent Markets
Google's parent Alphabet surged nearly 9% as Warren Buffett took a position and its new AI model, Gemini 3, gained ground on ChatGPT. Explore the week's top stock stories from Canada.
India probes cough syrup deaths amid safety concerns
Indian officials are investigating whether safety failures led to children dying from contaminated cough syrup. Get the latest details on this developing health crisis.
Dye & Durham stock jumps 20% after Plantro offer
Dye & Durham shares skyrocket more than 20% following Plantro acquisition proposal. Get the latest details on this major Canadian business development and market reaction.
Eli Lilly Reaches $1 Trillion Valuation Milestone
Eli Lilly becomes the first pharmaceutical company to achieve a US$1 trillion market valuation, driven by unprecedented demand for its weight-loss treatments. Discover how this milestone reshapes the industry.
Denmark compensates for Novo Nordisk vision loss
Danish authorities provide compensation to patients experiencing vision loss linked to Novo Nordisk medications. Learn about the pharmaceutical safety developments affecting Canadian consumers.
TSX climbs with U.S. markets on strong Nvidia earnings
Canadian and U.S. stock markets gained momentum following Nvidia's impressive quarterly results. The S&P/TSX composite showed positive movement as investor confidence strengthened across North America.
Bitget Reaches $5B in Stock Futures Trading Volume
Bitget achieves $5 billion cumulative trading volume for stock futures, highlighting growing demand for tokenized traditional assets among Canadian investors.
Nvidia's $65B Forecast Sparks Late Stock Rally
Nvidia's blockbuster revenue forecast of $65 billion reignited Wall Street's AI rally, easing concerns about an AI spending bubble and boosting tech stocks late.
Nvidia beats earnings forecasts despite AI bubble fears
Nvidia surpasses analyst expectations with strong quarterly earnings, demonstrating resilience amid growing concerns about artificial intelligence market stability. Discover how the tech giant continues to thrive.
S&P 500, Nasdaq Rise Ahead of Nvidia Earnings
U.S. stock markets show mixed performance with S&P 500 and Nasdaq gaining while investors focus on Nvidia's upcoming earnings report and AI sector momentum.
U.S. crude stocks fall on higher demand, EIA says
U.S. crude oil inventories fell significantly due to rising demand, while fuel stockpiles increased, according to the EIA. Explore the key market drivers and implications.
Teva Launches Global Innovation Platform for Pharma Breakthroughs
Teva Pharmaceutical launches Rise, a global open innovation platform connecting startups with pharma challenges in AI, digital health and smart manufacturing to accelerate patient impact.
Journal sued over controversial antidepressant drug trial
A medical journal faces legal action after publishing a study promoting antidepressant use for youth depression treatment. The infamous drug trial returns to spotlight amid growing concerns.
Fake Viagra Sold at Toronto Store: Health Canada
Health Canada warns about counterfeit Viagra discovered at a Toronto convenience store. Learn how to identify fake medications and protect your health.
Stocks Running Out of Time for Year-End Rally
Wall Street's year-end Santa rally is in doubt as tech stocks falter and economic concerns grow. Analysts predict more pain ahead for investors.
Nvidia options signal $320B price swing after earnings
Nvidia's upcoming earnings report could trigger a massive $320 billion market value swing, according to options trading data. Discover what this means for investors.
Canadian stocks sink tracking Wall Street tech sell-off
Canadian shares decline as technology sector leads market downturn. BusinessNewsWorld reports on market movements and economic indicators affecting investors.
U.S. Stocks Fall as AI Rally Falters
The U.S. stock market declined sharply as Nvidia and other AI-focused stocks retreated. The Dow dropped over 550 points. Read more on the market shift and what's next.
Tech stocks send TSX lower amid market decline
Canadian tech stocks led market declines as S&P/TSX composite dropped. U.S. markets also fell while TransAlta acquired Ontario power plants for $95 million. Stay informed on market trends.
How to Safely Dispose of Expired Medications
Learn the correct methods for disposing expired or unused medications in Canada. Protect your family and environment with proper drug disposal practices.
Novo Nordisk rolls out $349 Wegovy cash price early
Novo Nordisk introduces $349 cash price for Wegovy weight-loss drug ahead of schedule. Learn how this affects Canadian healthcare access and affordability.
J&J buys Halda Therapeutics for $3.05 billion
Johnson & Johnson expands its oncology portfolio with $3.05 billion acquisition of Halda Therapeutics, strengthening its cancer treatment pipeline. Learn about this major healthcare investment.
Berkshire invests $4.9B in Alphabet shares
Warren Buffett's Berkshire Hathaway makes surprising $4.9 billion investment in Alphabet, sending Google parent company shares soaring. Discover the implications for tech investing.
Asian Shares Mixed Following U.S. Market Decline
Asian markets show mixed performance after U.S. stocks stumble. Currency traders monitor fluctuations as global markets navigate economic uncertainty. Stay informed on market developments.
Free Cash Flow Strategy Beats TSX by 8.2% Annually
The Canadian Free Cash portfolio delivered 16.1% average annual returns from 1999-2025, beating the TSX's 7.9%. Discover how focusing on low EV/FCF stocks creates investment success. Sign up for market insights.
Analysts Reveal TSX Stocks Poised for Carney Project Gains
Mark Carney announces six fast-tracked national projects. Discover which TSX stocks analysts recommend for investment opportunities in energy, critical minerals and infrastructure.
Investing in Carney's Projects & TSX Earnings Highlights
Mark Carney announces six fast-tracked national projects. Scotiabank reveals top stock picks, plus TSX winners like Stingray Group soaring 22% on acquisition news.
Page 2 of 4